(19)
(11)
EP 2 804 952 A2
(12)
(88)
Date of publication A3:
17.04.2014
(43)
Date of publication:
26.11.2014
Bulletin 2014/48
(21)
Application number:
12865606.3
(22)
Date of filing:
19.01.2012
(51)
International Patent Classification (IPC):
C12P
21/08
(2006.01)
A61K
39/00
(2006.01)
C07K
16/00
(2006.01)
(86)
International application number:
PCT/US2012/021888
(87)
International publication number:
WO 2013/109279
(
25.07.2013
Gazette 2013/30)
(84)
Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
(71)
Applicant:
Therapeutic Proteins International, LLC
Chicago, Illinois 60616 (US)
(72)
Inventor:
WILTON, Rosemarie
Elmhurst, Illinois 60126 (US)
(74)
Representative:
LifeTech IP Spies Danner & Partner Patentanwälte PartG mbB
Elsenheimerstrasse 47a
80687 München
80687 München (DE)
(54)
STABILIZATION OF THE ANTI-CD20 ANTIBODY RITUXIMAB